SOA24 Congress

Nikkiso

 

Profile

Nikkiso, a pioneer in blood purification products, strive to improve patient care and cost-efficiency in the ICU by advancing our medical technology. Our goal is to build and maintain the trust and peace of mind of the clinicians and nurses who use our products and the patients who need them.

The Medical Division of Nikkiso is one of the world’s leading manufacturers of products for both acute and chronic blood purification therapies. In today’s world, we understand the need to address your ability to consistently improve patient outcomes, ensure patient safety and improve cost-effectiveness over the entire life cycle of the machine.

Aquarius SystemTM with Aquarius+ software uses accuracy and simplicity to deliver CRRT or therapeutic plasma exchange therapies regardless of anticoagulant needs of the patient with a single line set. This allows the choice of anticoagulation best suited for every patient.

In addition to CRRT and TPE therapies, Aquarius+ can also facilitate hemoperfusion therapies utilising the wide range of emerging adsorbative cartridges used in these therapies depending on clinician preference.

SOA23 Roles
  • Nikkiso are Exhibitors at SOA23
  • You can find Nikkiso at stand number 55